A French laboratory will begin production of the COVID-19 coronavirus vaccine from Moderna Inc. in March, and in April another institution will launch doses of the drug from Pfizer Inc. and BioNTech, French Industry Minister Agnes Panier-Runache said Wednesday.
“Production at the first site will start in March and it will be the Moderna vaccine,” Panier-Runache said on RTL radio.
She clarified that production will be carried out in a laboratory managed by Recipharm, an organization that develops contracts for pharmaceutical products.
“Then in April, the vaccine production from Pfizer and BioNTech will be launched,” the minister added.
The production of this drug will be carried out by the laboratory of the Sanofi company and the Delpharm company. At the same time, Sanofi is developing its own vaccine against coronavirus.
According to Panier-Runache, in May it is planned to start creating a vaccine developed by the German firm CureVac. The Minister noted that the approval of the use of this drug is pending.
Earlier on Wednesday, French Foreign Minister Jean-Yves Le Drian said that no one in the country would interfere with the use of the Russian Sputnik V vaccine if the drug is approved.
On the eve, French President Emmanuel Macron announced that soon four facilities in the country will start producing vaccines against COVID-19.
In France, since the beginning of the pandemic, more than 3.2 million cases of COVID-19 infection have been detected, more than 77 thousand infected have died.
12,120 total views, 2 views today